πŸ‡ΊπŸ‡Έ FDA
Patent

US 12421310

CD47 binding agents

granted A61KA61K2039/505A61K45/06

Quick answer

US patent 12421310 (CD47 binding agents) held by CENTESSA PHARMACEUTICALS (UK) LIMITED expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CENTESSA PHARMACEUTICALS (UK) LIMITED
Grant date
Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K2039/505, A61K45/06, A61K47/6849, A61P